Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2007
12/06/2007CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/06/2007CA2653497A1 Heterocyclic compounds as calcium channel blockers
12/06/2007CA2653332A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653329A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2653222A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007CA2652158A1 Piperidinyl pyrimidine derivatives
12/06/2007CA2651373A1 Compounds and methods for modulating fxr
12/06/2007CA2650147A1 Benzazepine derivatives as monoamine reuptake inhibitors
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1861396A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
12/05/2007EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/05/2007EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/05/2007EP1861390A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/05/2007EP1861388A1 Potassium channel modulating agents and their medical use
12/05/2007EP1861382A1 Fused aromatic compounds having anti-diabetic activity
12/05/2007EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
12/05/2007EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands
12/05/2007EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
12/05/2007EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101084215A Piperidine and azetidine derivatives as GLYT1 inhibitors
12/05/2007CN101084214A 激酶抑制剂 Kinase inhibitors
12/05/2007CN101084212A Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
12/05/2007CN101084209A Compounds with Kv4 ion channel activity
12/05/2007CN101084201A Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
12/05/2007CN101084198A Substituted amino-pyrimidones and uses thereof
12/05/2007CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
12/05/2007CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase
12/05/2007CN101083994A Heterocyclic derivatives and their use as therapeutic agents
12/05/2007CN101083993A Heterocyclic derivatives and their use as therapeutic agents
12/05/2007CN101081847A Method for synthesizing N,N-dialkylamine phenyl-dipyrazole triazine structural light-sensitive molecule
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352808C Heterocyclic diamide invertebrate pest control agents
12/05/2007CN100352805C Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them
12/04/2007US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007US7304086 Inhibitors of glutaminyl cyclase
12/04/2007US7304085 Nitrogen-containing heteroaryl derivatives
12/04/2007US7304084 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304067 (S)-2-[(R)-5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304063 Inhibitors of Akt activity
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
12/04/2007US7304055 Succinoylamino lactams as inhibitors of Aβ protein production
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007US7304051 Quinoxaline compounds
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007CA2241495C N,n',n'''-tris{2,4-bis[(1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)alkylamino]-s-triazin-6-yl}-3,3'-ethylenediiminodipropylamines, their isomers and bridged derivatives and polymer compositions stabilized therewith
11/2007
11/29/2007WO2007137190A2 Functionally diverse macromolecules and their synthesis
11/29/2007WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136680A2 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007WO2007135969A1 Urea type cinnamide derivative
11/29/2007WO2007135527A2 Benzimidazolyl compounds
11/29/2007WO2007135417A1 Benzotriazepinone derivatives
11/29/2007WO2007135131A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007WO2007134862A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
11/29/2007WO2007134677A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007WO2007134578A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
11/29/2007WO2007084413A3 Methods for treating hepatitis c
11/29/2007WO2007065010A3 Anti-angiogenesis compounds
11/29/2007WO2007064478A3 Method for making nicotine hapten
11/29/2007WO2006128659A3 Piperazine derivative renin inhibitors.
11/29/2007WO2006095159A8 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
11/29/2007US20070276025 Indirubin-Type Compounds, Compositions, and Methods for Their Use
11/29/2007US20070276020 Dicationic Compounds For Activity Against Trichomonas Vaginalis
11/29/2007US20070276010 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke
11/29/2007US20070276002 Compounds and Compositions as Channel Activating Protease Inhibitors
11/29/2007US20070275988 Transition state structure and inhibitors of thymidine phosphorylases
11/29/2007US20070275976 N-phenylpyrazole derivatives as pesticides
11/29/2007US20070275975 3-quinuclidinyl amino-substituted biaryl derivatives
11/29/2007US20070275967 Pyrazolinols
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007US20070275953 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties
11/29/2007US20070275944 Antioxidants and methods of their use
11/29/2007DE102006024834A1 Neue Indol-Pyrrol-Derivate und deren Verwendung New indole-pyrrole derivatives and their use
11/29/2007CA2688206A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
11/29/2007CA2655416A1 Pesticidal compositions for treating arthropods and methods for the use thereof
11/29/2007CA2652393A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007CA2651396A1 Urea type cinnamide derivative
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007CA2649707A1 Substituted pyrazinone derivatives for use as a medicine